CAMBRIDGE, Mass., November 27, 2024--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company ...
Novo Nordisk announced today that Wegovy® (semaglutide injection) is now approved to reduce the risk of non-fatal myocardial ...
Camtek Ltd. , today announced that it has received over $50 million in initial orders from several customers for its new Hawk product, with additional orders in the pipeline. These orders will be ...
He also held leadership roles at Tolerx and Alnylam. Tony serves on the boards of Etherna, Chimeron Bio, Helfie AI and Lift ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback